Angiodroid Spa news
We are glad to announce the beginning of a new exciting adventure for the distribution in Poland for our Automated CO2 Angiography technology, together with an exclusive partner: BERTZ MEDICAL.
“We are a dynamically developing company operating on the market of distribution and servicing of medical devices, and our primary value is to maintain the highest standards of offer and customer service – explains Jaroslaw, BERTZ CEO – our experienced team guarantee
recently gave an interview in which he illustrated the peculiarities of automatic CO2 angiography. In this interview, Prof. Sandhu remarked the Angiodroid technology. Here is a brief excerpt:
“A recently developed injector with a very novel method to map these vessels is to use carbon dioxide as a contrast agent which is safe in these patients es
Congrats to Dr. Ismazizi B. Zaharudin and to the team of Kuala Lumpur National Heart Center – Institut Jantung Negara – for choosing CO2 as a #first contrast agent, saving the renal function of their patients. Amazing job with 40 patients treated in jus
This is a round table discussion about CO2 during EVAR and complex EVAR in the framework of our Annual Meeting of Angiodroid in Bologna, Italy.
In this round table discussion, 5 European experts present current evidence and their experience about the use of CO2 in the treatment of aortic diseases .
Moreover, the panellists discuss all important benef
The number 500 is associated, for Italian culture, with a famous car that has marked the history of evolution and progress. We are particularly attached to this number, today more than ever.
In 2021, Angiodroid exceeded 500 injectors on the market, opening up to a new age: despite the difficult times given by the Covid-19 pandemic, Angiodroid reached this milestone, which marks a new beginning for the development of the Company.
We are committed every day, wi